David S. DeMarco, President and CEO of Arrow Financial Corp (NASDAQ:AROW), filed a Form 4 on September 9, 2026, disclosing stock option exercise and share withholding transactions dated September 4, 2026.

Key Highlights

  • Option exercise: DeMarco exercised an employee stock option (transaction code M) for 1,771 shares of common stock at a conversion price of $30.26 on September 4, 2026.
  • Shares withheld: 1,504 shares were disposed of (transaction code F) at $39.57 per share on the same date, reflecting tax withholding or similar settlement.
  • Direct ownership following transactions: DeMarco directly holds 95,826 shares of Arrow Financial common stock, per the filing.
  • Indirect ownership: An additional 3,035 shares are held indirectly through a 401(k) plan.
  • Option fully exercised: Following the transaction, zero employee stock options with a $30.26 exercise price remain, according to the filing.
  • DRIP shares noted: The filing discloses that 29 shares were acquired under the company's DRIP since August 28, 2026, included to reflect total holdings as of the filing date.

DeMarco's September 2026 Arrow Financial Share Transactions

According to the Form 4 filed with the SEC on September 9, 2026, David S. DeMarco, serving as President and CEO of Arrow Financial Corp, executed two non-derivative securities transactions on September 4, 2026. First, DeMarco acquired 1,771 shares of common stock through the exercise of an employee stock option at a price of $30.26 per share (transaction code M), bringing his directly held total to 97,301 shares at that point.

In the same transaction date, 1,504 shares were disposed of at $39.57 per share (transaction code F), reducing his direct holdings to 95,826 shares. The filing also reports 3,035 shares held indirectly through a 401(k) plan. A footnote in the filing states that the totals reflect 29 shares acquired under the company's dividend reinvestment plan (DRIP) since August 28, 2026, which "were not required to be reported on a Form 4" but are "being furnished to disclose the total holdings of the insider as of the date of this Form 4."

Regarding the derivative securities, the filing indicates the exercised employee stock option carried a $30.26 exercise price, had vested "in four equal installments beginning January 25, 2018," and carried an expiration date of January 25, 2027. Following the exercise of all 1,771 option shares, zero options under this grant remain. The Form 4 was signed by Penko Ivanov as Attorney in Fact on September 9, 2026.

What Was Disclosed

Arrow Financial Corp's President and CEO disclosed the exercise of 1,771 stock options at $30.26 and the subsequent disposition of 1,504 shares at $39.57 on September 4, 2026, leaving him with 95,826 directly held shares and 3,035 shares held via a 401(k).